Literature DB >> 12416738

The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea.

Hee Je Kim1, Soo Jeong Park, Hyun Woo Im, Dong Wook Kim, Woo Sung Min, Hack Ki Kim, Won Il Kim, Kwang Sung Kim, Chun Choo Kim.   

Abstract

We analyzed the association of HLA antigens with incidence of organ-specific graft-versus-host disease (GVHD) after allogeneic hemopoietic stem cell transplantation (allo-HSCT) from an HLA-matched sibling donor. We retrospectively reviewed the clinical records of allo-HSCT recipients and found 389 patients who had received matched-sibling HSCT. HLA types, GVHD grades, and the development of acute or chronic GVHD, factors that reflect a certain immunological impact associated with involved organs, were investigated. The overall incidence of acute and chronic GVHD was 24.8% (96 cases) and 21.2% (82 cases), respectively. The incidence of acute GVHD with grades II through IV was higher among patients who had HLA-B61 (P = .0153) and HLA-Cw3 (P = .0208). The donor sex (P = .0040) and the conditioning regimen (P = .0010) were also associated with severe acute GVHD. The extensive-type chronic GVHD incidence was higher in patients who had HLA-B54 (P = .0159). The donor sex (P = .0406) and the pretransplantation diagnosis (P = .0184) were other factors associated with the development of extensive-type chronic GVHD. Furthermore, HLA-B35 (P = .0226) and HLA-B54 (P = .0091) were associated with a higher incidence of severe acute skin GVHD and chronic skin and oral GVHD (in descending order of incidence rates). HLA-B7,27 was associated with chronic liver GVHD (P = .0476) in addition to other parameters including patient (P = .0246) and donor sex (P = .0019). This study shows that these remarkable HLA antigens may be potent transplantation immune regulators, but there is a need for further evaluation using larger study samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416738     DOI: 10.1007/bf02982797

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  9 in total

1.  Chronic graft-versus-host disease and HLA-DR4 in the southern German population.

Authors:  G Pawelec; C A Müller; M Haen; G Ehninger
Journal:  Br J Haematol       Date:  1990-06       Impact factor: 6.998

2.  Histocompatibility antigen DR4 is associated with chronic graft-versus-host disease in the south Wales population.

Authors:  J A Holmes; J A Whittaker
Journal:  Br J Haematol       Date:  1989-11       Impact factor: 6.998

3.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

4.  Risk factors for acute graft-versus-host disease.

Authors:  R P Gale; M M Bortin; D W van Bekkum; J C Biggs; K A Dicke; E Gluckman; R A Good; R G Hoffmann; H E Kay; J H Kersey
Journal:  Br J Haematol       Date:  1987-12       Impact factor: 6.998

5.  Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.

Authors:  D Weisdorf; R Hakke; B Blazar; W Miller; P McGlave; N Ramsay; J Kersey; A Filipovich
Journal:  Transplantation       Date:  1991-06       Impact factor: 4.939

6.  Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow.

Authors:  D S Bross; P J Tutschka; E R Farmer; W E Beschorner; H G Braine; E D Mellits; W B Bias; G W Santos
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

7.  Association between HLA-B antigens and acute graft-versus-host disease.

Authors:  R Storb; R L Prentice; J A Hansen; E D Thomas
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

8.  Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

Authors:  R Storb; R L Prentice; K M Sullivan; H M Shulman; H J Deeg; K C Doney; C D Buckner; R A Clift; R P Witherspoon; F A Appelbaum; J E Sanders; P S Stewart; E D Thomas
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

9.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

  9 in total
  2 in total

1.  Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.

Authors:  Dong-Mei Han; Xiao-Li Zheng; Li Ding; Hong-Min Yan; Zhi-Dong Wang; Mei Xue; Ling Zhu; Jing Liu; Heng-Xiang Wang
Journal:  Int J Hematol       Date:  2017-08-20       Impact factor: 2.490

2.  Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation.

Authors:  Fa-Hong Yan; Mei Wang; Jian-Feng Yao; Er-Lie Jiang; Ming-Zhe Han
Journal:  Chin Med J (Engl)       Date:  2017-06-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.